Next Article in Journal
Anticoagulant Effect of Snow mountain garlic: In Vitro Evaluation of Aqueous Extract
Next Article in Special Issue
Anti-Cancer Strategy Based on Changes in the Role of Autophagy Depending on the Survival Environment and Tumorigenesis Stages
Previous Article in Journal
Longitudinal and Transverse 1H Nuclear Magnetic Resonance Relaxivities of Lanthanide Ions in Aqueous Solution up to 1.4 GHz/33 T
Previous Article in Special Issue
Preparation and Tumor Inhibitory Activity of Tricin from Carex Meyeriana Kunth
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Thiazolidinedione-Conjugated Lupeol Derivatives as Potent Anticancer Agents Through a Mitochondria-Mediated Apoptotic Pathway

1
College of Pharmacy, Qiqihar Medical University, Qiqihar 161006, China
2
Research Institute of Medicine & Pharmacy, Qiqihar Medical University, Qiqihar 161006, China
*
Authors to whom correspondence should be addressed.
Molecules 2024, 29(20), 4957; https://doi.org/10.3390/molecules29204957
Submission received: 30 August 2024 / Revised: 13 October 2024 / Accepted: 18 October 2024 / Published: 20 October 2024
(This article belongs to the Special Issue Anticancer Drug Discovery and Development II)

Abstract

To improve the potential of lupeol against cancer cells, a privileged structure, thiazolidinedione, was introduced into its C-3 hydroxy group with ester, piperazine-carbamate, or ethylenediamine as a linker, and three series of thiazolidinedione-conjugated compounds (6ai, 9ai, and 12ai) were prepared. The target compounds were evaluated for their cytotoxic activities against human lung cancer A549, human breast cancer MCF-7, human hepatocarcinoma HepG2, and human hepatic LO2 cell lines, and the results revealed that most of the compounds displayed improved potency over lupeol. Compound 12i exhibited significant activity against the HepG2 cell line, with an IC50 value of 4.40 μM, which is 9.9-fold more potent than lupeol (IC50 = 43.62 μM). Mechanistic studies suggested that 12i could induce HepG2 cell apoptosis, as evidenced by AO/EB staining and annexin V-FITC/propidium iodide dual staining assays. Western blot analysis suggested that compound 12i can upregulate Bax expression, downregulate Bcl-2 expression, and activate the mitochondria-mediated apoptotic pathway. Collectively, compound 12i is worthy of further investigation to support the discovery of effective agents against cancer.
Keywords: triterpenoid; lupeol; thiazolidinedione; hybrids; antitumor; apoptotic triterpenoid; lupeol; thiazolidinedione; hybrids; antitumor; apoptotic
Graphical Abstract

Share and Cite

MDPI and ACS Style

Deng, S.; Zhao, Y.; Guo, X.; Hong, X.; Li, G.; Wang, Y.; Li, Q.; Bu, M.; Wang, M. Thiazolidinedione-Conjugated Lupeol Derivatives as Potent Anticancer Agents Through a Mitochondria-Mediated Apoptotic Pathway. Molecules 2024, 29, 4957. https://doi.org/10.3390/molecules29204957

AMA Style

Deng S, Zhao Y, Guo X, Hong X, Li G, Wang Y, Li Q, Bu M, Wang M. Thiazolidinedione-Conjugated Lupeol Derivatives as Potent Anticancer Agents Through a Mitochondria-Mediated Apoptotic Pathway. Molecules. 2024; 29(20):4957. https://doi.org/10.3390/molecules29204957

Chicago/Turabian Style

Deng, Siqi, Yinxu Zhao, Xiaoshan Guo, Xian Hong, Gang Li, Yuchun Wang, Qingyi Li, Ming Bu, and Ming Wang. 2024. "Thiazolidinedione-Conjugated Lupeol Derivatives as Potent Anticancer Agents Through a Mitochondria-Mediated Apoptotic Pathway" Molecules 29, no. 20: 4957. https://doi.org/10.3390/molecules29204957

APA Style

Deng, S., Zhao, Y., Guo, X., Hong, X., Li, G., Wang, Y., Li, Q., Bu, M., & Wang, M. (2024). Thiazolidinedione-Conjugated Lupeol Derivatives as Potent Anticancer Agents Through a Mitochondria-Mediated Apoptotic Pathway. Molecules, 29(20), 4957. https://doi.org/10.3390/molecules29204957

Article Metrics

Back to TopTop